Frontlight ResearchEarly access
Trial site
Instituto de Investigaciones Clinicas Zarate
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Heart failure3 trials
- Stroke3 trials
- Chronic kidney disease2 trials
- Coronary artery disease2 trials
- Type 2 diabetes2 trials
- Atrial fibrillation1 trial
- Lupus (SLE)1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Amgen3 trials
- Janssen Research & Development, LLC1 trial
- Novo Nordisk A/S1 trial
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
Closed trials
Terminated
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026